Hub genes including FANCI, POSTN, IFIH1, ZMYND10, PACRG and POU2AF1 might serve as novel biomarkers for precision diagnosis and providing medical treatment for patient with NPC. This evidence concerns the gene POU2AF1 and nasopharyngeal carcinoma.